Global PE firms line up for IndiaRF’s Synthimed Labs in $150-200 million deal
General Atlantic, KKR and CVC are among global PE firms evaluating a minority stake in IndiaRF-backed Synthimed, which is seeking a $1 billion valuation ahead of a planned IPO.
General Atlantic, KKR and CVC are among global PE firms evaluating a minority stake in IndiaRF-backed Synthimed, which is seeking a $1 billion valuation ahead of a planned IPO.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
